硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 Survivin 抗体对
试剂盒

人 Survivin 抗体对

01AB02537

Baculoviral IAP repeat-containing protein 5 (BIRC5), commonly known as survivin, is a crucial member of the inhibitor of apoptosis (IAP) family. BIRC5 is involved in cell cycle regulation and is specifically expressed during the G2-M phase, highlighting its role in mitosis. Furthermore, this protein plays a significant role in inhibiting apoptosis, thereby promoting cell survival, particularly in cancer cells. BIRC5 is characterized by its ability to bind and inhibit caspases, which are essential for the apoptotic process. Its expression is notably elevated in various cancers, including breast, prostate, and colorectal cancers, where it contributes to tumor growth and resistance to chemotherapy. In addition to cancer, aberrant BIRC5 expression has been linked to other diseases, such as cardiovascular diseases and chronic inflammatory conditions.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
BIRC5
基因别名
API4; IAP4
蛋白别名
baculoviral IAP repeat containing 5; Survivin
UniProt
O15392
物种
Human

产品详情

靶点名称
Survivin
蛋白名称
baculoviral IAP repeat containing 5
蛋白别名
Baculoviral IAP repeat-containing protein 5; Apoptosis inhibitor 4; Apoptosis inhibitor survivin
靶点基因名
BIRC5
基因别名
API4; IAP4
UniProt
O15392
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Baculoviral IAP repeat-containing protein 5 (BIRC5), commonly known as survivin, is a crucial member of the inhibitor of apoptosis (IAP) family. BIRC5 is involved in cell cycle regulation and is specifically expressed during the G2-M phase, highlighting its role in mitosis. Furthermore, this protein plays a significant role in inhibiting apoptosis, thereby promoting cell survival, particularly in cancer cells. BIRC5 is characterized by its ability to bind and inhibit caspases, which are essential for the apoptotic process. Its expression is notably elevated in various cancers, including breast, prostate, and colorectal cancers, where it contributes to tumor growth and resistance to chemotherapy. In addition to cancer, aberrant BIRC5 expression has been linked to other diseases, such as cardiovascular diseases and chronic inflammatory conditions.